Norelgestromin

Ortho Evra, Evra (norelgestromin) is a small molecule pharmaceutical. Norelgestromin was first approved as Ortho Evra on 2001-11-20. It is used to treat amenorrhea and uterine hemorrhage in the USA. It has been approved in Europe to treat contraception. It is known to target short transient receptor potential channel 3 and short transient receptor potential channel 6.